• Vascular-system-343x295

Webinar: MAPPs – New Tools for Decision Making

April 14th, 2:00 pm - 3:00 pm CEST

What is the current status of MAPPs in Europe and the US?

  • Luca Pani, Director General, Italian Medicines Agency
  • Gigi Hirsch, Executive Director, CBI and Program Director, NEWDIGS, MIT, USA
  • James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline, UK
  • Duane Schulthess, Managing Director, Vital Transformation (moderator)

  • riga-295x295

Riga Health Conference – Universal health: Investing in Health and Wellbeing for All

June 29th-30th, 2015 Radison BLU Hotel Latvija, Riga, Latvia

Topics will include:
  • Investing in Efficient European Health Systems which Prevent Disease
  • Ensuring Improved Health Outcomes and Reduced Inequalities
  • Developing Systems for People Centred and Sustainable Health Service Delivery

Programme - Speakers - Request your Invitation

Supporting Partners:

  • MPNE

Partner Event: MPNE 2015 – The risk of not taking risks in melanoma

24th- 26th April 2015

Boulevard Adolphe Max 98
1000 Brussels - Belgium
click here for more info  


  • ABPI web logo

Report: The challenges and changes needed to reengineer medicines development in the UK

March 9th, 2015|Comments Off

A new report from the ABPI and Vermilion Life Sciences examines the challenges and changes needed for the UK to lead reengineering medicines development, and proposes a new methodology to achieve this.

  • Magda_Chlebus

21st Century Cures Moves Towards Development of MAPPs Infrastructures and Methodologies

February 6th, 2015|Comments Off

Feb 6th, 2015 - by Magda Chlebus
While Europe is leading in the development of tools and methodologies in Medicine’s Adaptive Pathways (MAPPs) through the EMA live pilots and upcoming projects in IMI2, the key bottlenecks still holding back its implementation in Europe are gaining traction with the United States congress. This situation illustrates our need in Europe to move quickly and develop implementation strategies and foster political support for MAPPs whilst we still hold the drive and initiative. Read more

  • IOM_Sharing Data_hi res cover-small

Independent report points the way forward for the responsible sharing of clinical trial data

January 15th, 2015|Comments Off

A new culture is needed to promote the equitable and open sharing of data, to advance science, whilst protecting the interests of all stakeholders, says the US Institute of Medicine
The sharing of clinical trials data is clearly in the public interest, but huge effort is required to develop the policies and put in place the technical infrastructure and create a culture of openness, according to a new report from the US Institute of Medicine (IOM).

  • cover-multi

Conference Report: Digital Health – Catapulting Personalised Medicine Forward

December 12th, 2014|Comments Off

In a ground-breaking collaboration, The UK’s Digital Catapult, The Fellowship of Post Graduate Medicine, IDEALondon, and Vital Transformation brought together the best and brightest minds in Europe working at the frontiers of research where Personalised Medicines and Health Technologies intersect. This round table demonstrated how next-generation technologies and social media will integrate with public health, thus facilitating the burgeoning market for personalised medicines. The sessions included disruptive start-ups and technology savvy practitioners finding common ground in the desire to bring stratified medicines to patients.